Teva Pharmaceutical Industries Limited (TEVA)

業務介紹

Teva Pharmaceutical Industries Limited（Teva製藥工業有限公司）是一家製藥公司，主要在北美、歐洲和國際市場開發、製造、銷售和分銷仿製藥、特殊藥品和生物製藥產品。該公司提供各種劑型的無菌產品、激素、高效藥物和細胞毒性物質，包括片劑、膠囊、注射劑、吸入劑、液體、貼片、軟膏和乳膏。它還開發、製造和銷售活性藥物成分。此外，該公司專注於中樞神經系統、疼痛、呼吸和腫瘤領域。其中樞神經系統產品包括Copaxone（用於治療多發性硬化的復發型）、AJOVY（用於預防治療偏頭痛）和AUSTEDO（用於治療遲發性運動失調和與亨廷頓病相關的舞蹈症）。該公司在呼吸市場的產品包括ProAir、QVAR、ProAir Digihaler、AirDuo Digihaler和ArmonAir Digihaler、BRALTUS、CINQAIR/CINQAERO、DuoResp Spiromax和AirDuo RespiClick/ArmonAir RespiClick（用於治療哮喘和慢性阻塞性肺疾病）。其腫瘤市場的產品包括Bendeka、Treanda、Granix、Trisenox、Lonquex和Tevagrastim/Ratiograstim。Teva Pharmaceutical Industries Limited與MedinCell合作開發和商業化多種長效注射產品，包括用於治療精神分裂症患者的利培酮懸浮劑。該公司成立於1901年，總部位於以色列特拉維夫雅法。

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

公司網址

https://www.tevapharm.com